Related Content
Search Google Scholar for:
|
|
Science 23 March 1990: Vol. 247. no. 4949, pp. 1461 - 1465 DOI: 10.1126/science.2321008
|
|
Articles
Science, Vol 247, Issue 4949, 1461-1465
Copyright © 1990 by American Association for the Advancement of Science
Engineering human prolactin to bind to the human growth hormone receptor
BC Cunningham,
DJ Henner,
and
JA Wells
Department of Protein Engineering, Genentech, Inc. South San Francisco, CA 94080.
A strategy of iterative site-directed mutagenesis and binding analysis was used to incorporate the receptor-binding determinants from human growth hormone (hGH) into the nonbinding homolog, human prolactin (hPRL). The complementary DNA for hPRL was cloned, expressed in Escherichia coli, and mutated to introduce sequentially those substitutions from hGH that were predicted by alanine-scanning mutagenesis and other studies to be most critical for binding to the hGH receptor from human liver. After seven rounds of site-specific mutagenesis, a variant of hPRL was obtained containing eight mutations with an association constant for the hGH receptor that was increased more than 10,000-fold. This hPRL variant binds one-sixth as strongly as wild-type hGH, but shares only 26 percent overall sequence identity with hGH. These studies show the feasibility of recruiting receptor-binding properties from distantly related and functionally divergent hormones and show that a detailed functional database can be used to guide the design of a protein-protein interface in the absence of direct structural information.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Two Wrongs Can Make a Right: Dimers of Prolactin and Growth Hormone Receptor Antagonists Behave as Agonists.
- J. F. Langenheim, D. Tan, A. M. Walker, and W. Y. Chen (2006)
Mol. Endocrinol.
20, 661-674
| Abstract »
| Full Text »
| PDF »
- Shotgun Alanine Scanning Shows That Growth Hormone Can Bind Productively to Its Receptor through a Drastically Minimized Interface.
- J.-L. K. Kouadio, J. R. Horn, G. Pal, and A. A. Kossiakoff (2005)
J. Biol. Chem.
280, 25524-25532
| Abstract »
| Full Text »
| PDF »
- Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization.
- B. Bernat, G. Pal, M. Sun, and A. A. Kossiakoff (2003)
PNAS
100, 952-957
| Abstract »
| Full Text »
| PDF »
- Aggregation of Human Wild-Type and H27A-Prolactin in Cells and in Solution: Roles of Zn2+, Cu2+, and pH.
- B.-J. Sankoorikal, Y. L. Zhu, M. E. Hodsdon, E. Lolis, and P. S. Dannies (2002)
Endocrinology
143, 1302-1309
| Abstract »
| Full Text »
| PDF »
- Expression of Prolactin and Its Receptor in Human Breast Carcinoma.
- C. Reynolds, K. T. Montone, C. M. Powell, J. E. Tomaszewski, and C. V. Clevenger (1997)
Endocrinology
138, 5555-5560
| Abstract »
| Full Text »
| PDF »
- Inefficient Secretion of Human H27A-Prolactin, a Mutant That Does Not Bind Zn2+.
- Z. Sun, M. S. Lee, H. K. Rhee, J. M. Arrandale, and P. S. Dannies (1997)
Mol. Endocrinol.
11, 1544-1551
| Abstract »
| Full Text »
- Changing the Structural Context of a Functional beta-Hairpin.
- E. Drakopoulou, S. Zinn-Justin, M. Guenneugues, B. Gilquin, A. Ménez, and C. Vita (1996)
J. Biol. Chem.
271, 11979-11987
| Abstract »
| Full Text »
| PDF »
- Minimization of a Polypeptide Hormone.
- B. Li, J. Y. K. Tom, D. Oare, R. Yen, W. J. Fairbrother, J. A. Wells, and B. C. Cunningham (1995)
Science
270, 1657-1660
| Abstract »
| PDF »
- Rational Design of Potent Antagonists to the Human Growth Hormone Receptor.
- G. Fuh, B. C. Cunningham, R. Fukunaga, S. Nagata, D. V. Goeddel, and J. A. Wells (1992)
Science
256, 1677-1680
| Abstract »
| PDF »
- Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.
- B. Cunningham, M Ultsch, A. De Vos, M. Mulkerrin, K. Clauser, and J. Wells (1991)
Science
254, 821-825
| Abstract »
| PDF »
- Zinc mediation of the binding of human growth hormone to the human prolactin receptor.
- B. Cunningham, S Bass, G Fuh, and J. Wells (1990)
Science
250, 1709-1712
| Abstract »
| PDF »
|
|